Skip to content
RDL Network logo
Corrigendum to: “Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells” [Toxicol. Rep. Volume 13, December 2024, 101765] — Hossein Majidzadeh (2025) | RDL Network